Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene

Cancer Immunology Immunotherapy

Volumn 46, Issue 3, 1998, Pages 137-146

  Dong, Zhongyun ^a   Juang, Shin Hun ^a   Kumar, Rakesh ^a   Eue, Ines ^a   Xie, Keping ^a   Bielenberg, Diane ^a   Lu, Weixin ^a   Bucana, Corazon ^a   Yang, Xiulan ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Fibrosarcoma; Gene therapy; Interferon ; Macrophages; NK cells

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FEMALE; FIBROSARCOMA; GENE; GENE THERAPY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFECTION; MACROPHAGE; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RETROVIRUS;

EID: 7144228619     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050472     Document Type: Article

References (42)

1. Bulbul MA, Huben RP, Murphy GP (1986) Interferon-beta treatment of metastatic prostate cancer. J Surg Oncol 33:231
2. Dong Z, Ward NE, Fan D, Gupta KP, O'Brian CA (1991) In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol Pharmacol 39:563
3. Dong Z, Qi X, Fidler IJ (1993) Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J Exp Med 177:1071
4. Dong Z, O'Brian, Fidler IJ (1993) Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J Leukoc Biol 53:5324
5. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ (1994) Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86:913
6. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54:789
7. Dong Z, Kumar R, Yang X, Fidler IJ (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88:801
8. Einhorn S, Grander D (1996) Why do so many cancer patients fail to respond to interferon therapy? J Interferon Cytokine Res 16:275
9. Fabra A, Nakajima M, Bucana CD, Fidler IJ (1992) Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation 52:101
10. Fleischmann CM, Stanton GJ, Fleischmann WR Jr (1996) Enhanced in vivo sensitivity in in vitro interferon-treated B16 melanoma cells to CD8 cells and activated macrophages. J Interferon Cytokine Res 16:805
11. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65
12. Folkman J, Ingber D (1992) Inhibition of angiogenesis. Semin Cancer Biol 3:89
13. Gohji K, Fidler IJ, Tsan R, Radinsky R, Eschenbach AC von, Tsuruo T, Nakajima M (1994) Human recombinant interferons beta and gamma decrease gelatinase production and invasion by human KG-2 renal carcinoma cells. Int J Cancer 58:380
14. Gorlach AP, Herter H, Hentschel, Frosch PJ, Acker H (1994) Effects of IFNβ and rIFN-γ on growth and morphology of two human melanoma cell lines: comparison between two- and three-dimensional culture. Int J Cancer 56:249
15. Hughes DA, Fraser IP, Gordon S (1994) Murine M phi scavenger receptor: adhesion function and expression. Immunol Lett 43:7
16. Issacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond [Biol] 147:258
17. Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW (1992) Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon-beta. J Natl Cancer Inst 84:1185
18. 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Int J Cancer 60:221
19. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T (1981) In vivo effects of anti-asialo GM1 antibody on natural killer activity. Nature 291:334
20. Kripke ML (1977) Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res 37:1395
21. Lokshin A, Mayotte JE, Levitt ML (1995) Mechanism of interferon-beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst 87:206
22. MacMicking JD, Nathan C, Honn G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641
23. Miller AD, Miller DG, Garcia JV, Lynch CM (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581
24. Mitsui YT, Senda T, Shimazu S, Matsuda J, Utsumi (1993) Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon beta. Pharmacol Ther 58:93
25. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J (1992) Downregulation of interleukin-8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 89:9049
26. Ortaldo JR, Herberman RB (1986) Augmentation of natural killer activity. In: Lotzova E (ed) Immunobiology of natural killer cells, vol II. CRC, Boca Raton, Fla, p 145
27. Raz A, Hanna N, Fidler IJ (1981) In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst 66:183
28. Riches DW, Underwood GA (1991) Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state. J Biol Chem 266:24785
29. Salmon P, Le Cotonnec JY, Galazka A, Abdul-Ahad A, Darragh A (1996) Pharmacokinetics and pharmacodynamics of recombinant human interferon-( in healthy male volunteers. J Interferon Cytokine Res 16:759
30. Sarkar S, Flores I, De La Rosa C, Ozzello L, Ron Y, Pestak S (1995) Injection of irradiated B16 melanoma genetically modified to secrete IFN-α causes regression of an established tumor. Int J Oncol 7:17
31. Schiller JH, Storer B, Bittner G, Wilson JK, Borden EC (1988) Phase II trial of a combination of interferon-beta ser and interFeron-gamma in patients with advanced malignant melanoma. J Interferon Res 8:581
32. Sen G, Ransohoff RM (1993) Interferon-induced antiviral actions and their regulation. Adv Virus Res 42:57
33. Sica G, Fabbroni L, Castagnetta L, Cacciatore M, Pavone-Macaluso M (1989) Antiproliferative effect of interferons on human prostate carcinoma cell lines. Urol Res 17:111
34. Sica G, Fabbroni L, Dell'Acqua G, Iacopino F, Marchetti P, Cacciatore M, Pavone-Macaluso M (1991) Natural beta-interferon and androgen receptors in prostatic cancer cells. Urol Int 46:159
35. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ (1995) Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562
36. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980). Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J Natl Cancer Inst 65:929
37. Talmadge JE, Wolman SR, Fidler IJ (1982). Evidence for the clonal origin of spontaneous metastases. Science 217:361
38. Thomas H, Balkwill FR (1991) Effects of interferons and other cytokines on tumors in animals: a review. Pharmacol Ther 52:307
39. Uze G, Lutgalla G, Morgensen KE (1995) Alpha and beta interferons and their receptor and their friends and relations. J Interferon Cytokine Res 15:3
40. Van Damme J, Opdenakker G. (1990) Interaction of interferons with skin reactive cytokines: from interleukin-1 to interleukin-8. J Invest Dermatol 95:906
41. Wolman SR, McMorrow LE, Fidler IJ, Talmadge JE (1985) Development and progression of karyotypic variability in melanoma K-1735 following X-irradiation. Cancer Res 45:1839
42. Zhang X, Alley EW, Russell SW, Morrison DC (1994) Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect Immunol 62:33